Suggestions
Francie Barron
VP Innovation Partnerships
Francie Barron, PhD, is a seasoned professional in the biotechnology industry with extensive experience in research, development, and strategic partnerships. She currently serves as the VP Biosensor Business Development at Paragraf®, a position she has held since April 2023.1
Prior to her current role, Dr. Barron was the VP Innovation Partnerships at Cardea Bio Inc. from September 2019 to April 2023.1 During her tenure at Cardea, she was responsible for building commercial and academic partnerships to bring "Powered by Cardea" products from ideation to launch.2 She played a crucial role in driving the "Internet of Biology" movement by shaping new strategic alliances with pharmaceutical and academic partners to integrate graphene field effect transistors into new products.3
Dr. Barron's career highlights include:
Education and Early Career
- PhD in Cell Biology, Stem Cells, and Development from the University of Colorado Denver Anschutz Medical Campus3
- BS in Biochemistry/Cell Biology from the University of California, San Diego3
- Postdoctoral fellowship at Stanford University School of Medicine, where she was awarded an NIH training grant13
Professional Experience
- Held various positions at Cardea Bio Inc., including VP R&D and Regulatory Affairs1
- Worked at Nanomedical Diagnostics, Inc. as VP R&D and Regulatory Affairs1
- Managed a lab at the Ludwig Institute for Cancer Research, designing and producing novel antibodies3
Achievements and Contributions
- Awarded a DARPA grant to develop therapeutic drug monitoring at the hospital bedside3
- Led multiple successful product launches and novel nanotechnology-enabled applications3
- Published several peer-reviewed publications and white papers to support technology and product development3
- Contributed to the development of CRISPR-Chip, a technology combining CRISPR-Cas9 nucleotide detecting technology with graphene biosensor platforms45
Dr. Barron's expertise spans various areas, including graphene biosensors, infectious disease research, in vitro diagnostics, and field effect transistors.7 Her work has focused on developing innovative products for life science research, drug discovery, and portable diagnostic platforms.6


